| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 7 | |
| #2 | EPO (European Patent Office) | 4 | |
| #3 | Australia | 2 | |
| #4 | United States | 2 | |
| #5 | Canada | 1 | |
| #6 | China | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials | |
| #5 | Microorganisms | |
| #6 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Shichiri Masayoshi | 4 |
| #2 | Imakawa Kazuhiko | 3 |
| #3 | Ohara Osamu | 3 |
| #4 | Nagaoka Kentaro | 3 |
| #5 | Watanabe Fumiko | 3 |
| #6 | Watanabe Takuya | 3 |
| #7 | Nagase Takahiro | 3 |
| #8 | Okamoto Mitsuhiro | 2 |
| #9 | Ishibashi Kenichi | 2 |
| #10 | Abe Ryoji | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2009054483A1 | Drug containing salusin-β | |
| CN101687008A | The therapeutic agent and the detectable that are used for the targeting Salusin of arteriosclerotic disease | |
| WO2004022082A1 | Embryo implantation inhibitor | |
| EP1544295A1 | Salt-inducible kinases 2 and use thereof | |
| WO03072774A1 | K+ transporter and use thereof | |
| EP1437363A1 | Drug transporter and use thereof |